Cetuximab as salvage therapy in 82 year old women with metastatic colon cancer

被引：0
|
作者：
Krzemieniecki, Krzysztof [1 ]
机构：
[1] Uniwersytetu Med Krakowie, Coll Med, Klin Onkol, Ul Sniadeckich 10, PL-31531 Krakow, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2012年 / 8卷 / 02期
关键词：
metastatic colon cancer; elderly patients; cetuximab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Anticancer treatment offered to elderly requests basic knowledge on geriatric problems and understanding the limits related to reduced functional reserves. Cetuximab was prescribed as the rescue monotherapy to 82 years old women with metastatic colon cancer following failure of systemic treatment. The decrease in bothersome disease symptoms and temporary remission of metastatic lesions revealed in the imaging assessment were observed during treatment. Patient survived additional 10 months. Treatment was well tolerated and toxicity was easy manageable. Monotherapy with cetuximab can be a valuable palliative option in the adequately selected patients.
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [41] Effective salvage therapy with carboplatin/mitomycin C in metastatic breast cancer
    Baur, M
    Kienzer, H
    DeSantis, M
    Postner, G
    Pont, J
    Hudec, M
    Dittrich, C
    ONKOLOGIE, 2002, 25 (03): : 249 - 254
  • [42] Salvage therapy with bevacizumab, capecitabin, and mitomycin C (BECAM) for patients with metastatic colorectal or gastric cancer refractory to 5-fluorouracil, oxaliplatin, irinotecan, and cetuximab
    Peinert, S.
    Arnold, D.
    Grothe, W.
    Lesske, J.
    Siewczynski, R.
    Schaedlich, B.
    Kegel, T.
    Behrmann, C.
    Schmoll, H.-J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 226 - 226
  • [43] Impact of cetuximab-irinotecan salvage combination on overall survival (OS) in refractory metastatic colorectal cancer (mCRC)
    Seitz, JF
    Dahan, L
    Richard, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 304S - 304S
  • [44] A targeted approach for antiangiogenic therapy of metastatic human colon cancer
    Ellis, LM
    AMERICAN SURGEON, 2003, 69 (01) : 3 - 10
  • [45] Personalized T cell therapy for metastatic colon cancer.
    Ravindranathan, Sruthi
    Jajja, Mohammad Raheel
    Waller, Alexandra
    Bommireddy, RamireddV
    Petersen, Christopher
    Selvaraj, Periasamy
    Yang, Lily
    Lesinski, Gregory B.
    El-Rayes, Bassel F.
    Flynn, Brianna
    Waller, Edmund K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Coagulation abnormalities in patients with metastatic colon cancer on bevacizumab therapy
    Fradkina, P.
    Locker, G.
    Du, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Liver-Directed Therapy for Metastatic Colon Cancer: Update
    Waddell, John J.
    Townsend, Patricia H.
    Collins, Zachary S.
    Walter, Carissa
    CURRENT COLORECTAL CANCER REPORTS, 2022, 18 (01) : 18 - 25
  • [48] Liver-directed conversion therapy in metastatic colon cancer
    Snyder, Alexandra
    Kemeny, Nancy
    Shamseddine, Ali
    Al-Olayan, Ashwaq
    El-Merhi, Fadi
    Kelsen, David P.
    Jamali, Faek
    Sidani, Mustafa
    Mukherji, Deborah
    El-Naghy, Mahmoud
    O'Reilly, Eileen M.
    Saltz, Leonard B.
    Abou-Alfa, Ghassan K.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 6 (03) : 322 - 328
  • [49] Molecular Endomicroscopy Predicts Tumor Response to Cetuximab Therapy in Human Colon Cancer Xenografts
    Hoetker, Michael S.
    Kiesslich, Ralf
    Diken, Mustafa
    Galle, Peter R.
    Goetz, Martin
    GASTROENTEROLOGY, 2012, 142 (05) : S6 - S6
  • [50] An 85 year old man with widespread metastatic thyroid cancer
    Case Presentation
    中华老年多器官疾病杂志 , 2003, (03) : 225 - 228
12345